Advances in Motion provides health care professionals with information about the latest breakthroughs, research and clinical advances from Massachusetts General Hospital.
EXPLORE OUR SPECIALTIES BROWSE OUR TOPICS SUBSCRIBE TO RECEIVE UPDATES
Featured In Oncology
Developing a Personalized Approach for Targeted Radiotherapy of Liver Cancers
Researchers at Massachusetts General Hospital are developing computation models capable of increasing the precision of targeted delivery of radiotherapy to liver tumors.
Featured In Ophthalmology
Mass Eye and Ear Ophthalmology: Celebrating 200 Years of Excellence in Patient Care, Research, and Education
This year, Mass Eye and Ear is celebrating its 200th anniversary. To kick things off, we are highlighting some of the ophthalmology department’s most significant achievements in patient care, research, and education.
Featured In Neuroscience
Youth In Recovery Express Internalized Stigma and Resilience
Massachusetts General Hospital researchers found many adolescents in recovery experience internalized stigma and endorse stigmatized attitudes toward people who use alcohol and other drugs. These youth need safe places to disclose their status to people who understand their experience and will support their sobriety.
Featured In Cardiovascular
Women's Heart Health Program Aims to Reduce Disparities
A pioneering Massachusetts General Hospital clinical care, research, and education program aims to improve outcomes from cardiovascular disease in women.
Featured In Digestive Health
Vitamin C Might Have Clinical Benefit Against KRAS- and BRAF-mutated CRC
Shuji Ogino, MD, PhD, Mingyang Song, MBBS, ScD, and colleagues leveraged data from two large, prospective U.S. studies that showed the use of vitamin C after diagnosis of colorectal cancer with KRAS or BRAF mutations was associated with a 26% reduction in the risk of disease-specific mortality.
The Latest Orthopaedic Advances
Pathways Case Record: Profound Weight Loss in a Patient With Polymyositis and Small Bowel Inflammation
A patient presented with severe malnutrition and an unintentional estimated weight loss of 160 pounds over three years. The Pathways Consult Service at Massachusetts General Hospital investigated the patient's concomitant skeletal and smooth muscle inflammation and gut dysmotility.
Vancomycin–Gentamicin Calcium Sulfate Beads May Predispose to Polymicrobial Infections After Adult Spinal Deformity Surgery
Massachusetts General Hospital researchers conclude from a feasibility study that it's too soon to recommend widespread use of combination antibiotics as infection prophylaxis for spine surgery because adults receiving vancomycin–gentamicin calcium sulfate beads exhibited a propensity to polymicrobial infections.
Advances Specialties
Cardiovascular
CAD Prevalent in Patients With Type 2 MI but Usually Non-obstructive
Cian P. McCarthy, MBBCh, BAO, SM, James L. Januzzi, Jr., MD, and colleagues found in a prospective study that coronary artery disease affected 92% of patients with type 2 myocardial infarction, but despite a large overall burden of coronary plaque, 74% did not have hemodynamically significant focal stenosis.
Neuroscience
Heated Yoga Linked to Reduction of Moderate to Severe Depressive Symptoms in Randomized Controlled Trial
In 2021, a randomized controlled trial showed heated yoga outperformed a waitlist control in a group of women with mild-to-moderate depression. Researchers at Massachusetts General Hospital have extended the findings to a larger, mixed-gender, and more severely depressed population.
Oncology
Less Aggressive Protocol Suitable for Muscle-invasive Bladder Cancer in Noncystectomy Candidates
Douglas M. Dahl, MD, Jason A. Efstathiou, MD, DPhil, and colleagues determined that in patients with muscle-invasive bladder cancer who were not candidates for cystectomy or cisplatin, maximum tumor resection and chemoradiation were associated with high response rates and five-year overall survival rates of 25% to 38%.
May 10, 2024
Conference: Midlife Women's Health 2024: A Multidisciplinary Approach to Care
The Midlife Women's Health 2024 course is led by a multidisciplinary group of experts from Massachusetts General Hospital who will present on the evaluation and management of gynecologic cancers, cardiovascular health, menopausal hormone therapy, ADHD, sexuality after cancer, and more to assist clinicians in caring for their midlife patients. The entire program will be available to registrants for 30 days after the event, with CME credit provided only to those who log in on the day of the conference.
April 6-8, 2024
Conference: The American College of Cardiology's Annual Scientific Session & Expo
The American College of Cardiology (ACC) will host its Annual Scientific Session & Expo in Atlanta, GA, on April 6 – 8, 2024. ACC 2024 is your time to network with colleagues, see the latest science and innovation, and learn about practice-changing updates in care.